Bauduin et al.
(R)-(-)-methylphenyl-o-tolylphosphine borane 12c,17e,27 (()-
oxide was obtained by a one-pot procedure previously de-
scribed, involving decomplexation of 12g with DABCO and
then oxidation with tert-butyl hydroperoxide.16c
28
methyl-1-naphthylphenylphosphine borane 12d .27,
Their enantiomeric excesses have been determined by HPLC
analysis on a Chiralcel OK Daicel column, eluent: hexane/
ethanol 8:2, 1 mL/min, λ ) 254 nm: (R)-12b, tR ) 11 min;
(S)-12a , tR ) 21 min (12a is the enantiomer of 12b); (R)-12c,
tR ) 11 min; (S)-enantiomer, tR ) 15 min; (R)-12d , tR ) 21
min; (S)-enantiomer, tR ) 30 min.
(R)-(-)-o-An isylp h en yl-o-tolylp h osp h in e 14. The prepa-
ration of the phosphine 14 from the chlorophosphine borane
4c was achieved as described above for the phosphine borane.
However, after workup, a mixture of 14 and its borane complex
1
(31P NMR δ(ppm) 19.6, J PB ) 68.5) was obtained which was
(R)-(+)-Meth yl-2-n aph th ylph en ylph osph in e bor an e 12e:
taken up in ethanol and stirred overnight to complete the
20
yield ) 46%; colorless viscous oil; Rf ) 0.61 (toluene); [R]20
decomplexation: yield ) 92%; white crystals (EtOH); Rf ) 0.68
D
) +19.0 (c 1.3, CHCl3) for 81% ee; IR (KBr, ν cm-1) 3052-
2915, 2368-2337, 1437, 1089, 1068; 1H NMR (CDCl3) δ (ppm)
0.20-1.60 (3H, br), 1.82 (3H, d, 2J PH ) 10.1), 7.10-7.90 (11H,
m), 8.05-8.30 (1H, m); 13C NMR (CDCl3) δ (ppm) 11.9 (d, 1J PC
) 40.2), 126.8 (d, J PC ) 8.6), 127.0-129.0, 130.7 (d, J PC ) 56.3),
131.2 (d, J PC ) 2.4), 131.8 (d, J PC ) 9.6), 132.8 (d, J PC ) 11.7),
133.4 (d, J PC ) 10.9), 134.3 (d, J PC ) 2.0); 31P NMR (CDCl3) δ
(toluene); mp ) 134 °C; [R]25 ) -2.88 (c 1.0, CHCl3) for 99%
D
ee; IR (KBr, ν cm-1) 3035-2830, 1580, 1570, 1457, 1434, 1271,
1240, 1165, 1021, 794, 763, 745, 699; 1H NMR (CDCl3) δ (ppm)
2.33 (3H, s), 3.68 (3H, s), 6.53-6.58 (1H, m), 6.66-6.70 (1H,
m), 6.74-6.85 (2H, m), 6.95-7.05 (1H, m), 7.08-7.30 (8H, m);
13C NMR (CDCl3) δ (ppm) 21.2 (d, 3J PC ) 21.3), 55.7, 110.2 (d,
J PC ) 1.7), 121.1, 124.7 (d, J PC ) 11.6, 125.9, 128.3-128.6,
129.9 (d, J PC ) 4.6), 130.3, 132.8, 133.7, 134.0, 134.3, 135.3-
136.0, 142.3 (d, J PC ) 26.0), 161.3 (d, J PC ) 15.7); 31P NMR
(CDCl3) δ (ppm) -23.1; MS (DCI, CH4) m/z (relative intensity)
323 (M+ + H + CH4; 15), 307 (M+ + H; 100), 215 (M+ - o-Tol;
8), 199 (M+ - o-An; 6); HRMS (DCI, CH4) calcd for C20H20OP
[M+ + H] 307.1252, found 307.1255.
1
(ppm) +11.7 (q, J PB ) 67.5); MS (DCI, CH4) m/z (relative
intensity) 263 (M+ - H; 100), 250 (M+ - BH3; 20); HRMS (DCI,
CH4) calcd for C17H17BP [M+ - H] 263.1161, found 263.1168.
The enantiomeric excess of the methyl-2-naphthylphe-
nylphosphine borane 12e was determined by HPLC analysis
on a Chiralcel OK Daicel column, eluent: hexane/ethanol 8:2,
1 mL/min, λ ) 254 nm: (R)-12e, tR ) 19 min; (S)-enantiomer,
tR ) 27 min.
The enantiomeric purity of 14 was analyzed by comparison
with a racemic sample, by 31P NMR in the presence of (+)-di-
µ-chlorobis[2-[1-(dimethylamino)ethyl]phenyl-C,N]dipalladi-
um.30
(R)-(-)-Cyclop en t a d ien ylm et h ylp h en ylp h osp h in e
Bor a n e 15. The preparation of this compound from the
chlorophosphine borane 4a was carried out as previously
described.18a
P r ep a r a tion of th e P h osp h in ite Bor a n es 16-18. (S)-
(-)-Met h yl-O-(1-b r om o-2-n a p h t h yl)p h en ylp h osp h in it e
Bor a n e 16. The preparation of the compound 16 from the
chlorophosphine borane 4a has been previously described by
our group.18c
(R)-(-)-Meth yl-o-biph en ylph en ylph osph in e bor an e 12f:
29
yield ) 41%; white powder; Rf ) 0.70 (toluene); mp ) 117
°C; [R]20 ) -42.1 (c 1.0, CHCl3) for 99% ee; IR (KBr, ν cm-1
)
D
2964-2854, 2391-2330, 1437, 1073, 1061, 895, 888; 1H NMR
2
(CDCl3) δ (ppm) 0.10-1.81 (3H, br), 1.32 (3H, d, J PH ) 10.1),
6.90 (2H, m), 7.10-7.60 (11H, m), 8.00 (1H, m); 13C NMR
1
(CDCl3) δ (ppm) 11.8 (d, J PC ) 41.0), 127.4 (d, J PC ) 11.6),
127.6, 128.4 (d, J PC ) 10.2), 128.5 (d, J PC ) 52.1), 129.5, 130.4
(d, J PC ) 2.5), 130.9 (d, J PC ) 2.4), 131.2 (d, J PC ) 9.6), 131.5
(d, J PC ) 6.7), 132.3 (d, J PC ) 57.5), 134.4 (d, J PC ) 15.3), 140.6
(d, J PC ) 3.1), 146.9 (d, J PC ) 3.8); 31P NMR (CDCl3) δ (ppm)
1
+14.4 (q, J PB ) 77.3); MS (EI) m/z (relative intensity) 290
(R)-(-)-o-An isylp h en yl-O-p -t olylp h osp h in it e Bor a n e
17. In a 50 mL two-necked flask equipped with a magnetic
stirrer and an argon inlet was added 60 mg of NaH (60% in
mineral oil, 1,5 mmol), and the mixture was washed several
times with small amounts of dry pentane. A solution of 162
mg of p-cresol (1.5 mmol) in 8 mL of dry THF was then
introduced, and the mixture was stirred at room temperature
for 4 h. The p-cresolate was then added at -78 °C to a toluene
solution of chlorophosphine borane 4b (0.5 mmol) previously
prepared as described above. The resulting mixture was
progressively warmed to room temperature and stirred over-
night. After hydrolysis, the aqueous phase was extracted
several times with CH2Cl2. The combined organic layers were
dried over MgSO4, and the solvent was removed. The residue
was purified by chromatography on neutral aluminum oxide
using toluene as eluent to yield 142 mg of the phosphinite
borane 17: yield ) 85%; colorless crystals; mp ) 68 °C; Rf )
(M+; 15), 287 (M+ - 3H; 20), 276 (M+ - BH3; 60), 275 (M+
-
BH3 - H; 100), 183 (35), 163 (15), 123 (10); HRMS (EI) calcd
for C19H20BP [M+] 290.1400, found 290.1396. Anal. Calcd for
C
19H20BP (290.1508): C, 78.65; H, 6.95. Found: C, 78.76; H,
7.03.
The enantiomeric excess of the methyl-o-biphenylphenylphos-
phine borane 12f was determined by HPLC analysis on a
Chiralcel OK Daicel column, eluent: hexane/ethanol 70:30, 1
mL/min, λ ) 254 nm: (R)-12f, tR ) 10 min; (S)-enantiomer, tR
) 30 min.
(S)-(+)-Cycloh exylm eth ylph en ylph osph in e bor an e 12g:
yield ) 46%; colorless viscous oil; Rf ) 0.61 (toluene); [R]20
)
D
+9.1 (c 1.0, CHCl3) for 80% ee; IR (KBr, ν cm-1) 2930-2854,
2376, 1449, 1437, 1300, 1119, 1064, 1001, 920, 898, 881, 746,
1
694; H NMR (CDCl3) δ (ppm) 0.10-1.40 (3H, br), 1.08-1.39
2
(6H, m), 1.53 (3H, d, J PH ) 9.9), 1.57-1.94 (5H, m), 7.40-
7.55 (3H, m), 7.65-7.73 (2H, m); 13C NMR (CDCl3) δ (ppm)
0.6 (toluene); [R]20 ) -19.2 (c 1.1, CHCl3) for 97% ee; IR (ν
D
1
cm-1) 3060-2837 (CH), 2390, 2347, 1589, 1574, 1505, 1477,
7.7 (d, J PC ) 38.8), 25.8 (d, J PC ) 1.8), 26.3 (d, J PC ) 4.8),
1
26.4 (d, J PC ) 4.2), 26.6 (d, J PC ) 4.2), 35.8 (d, J PC ) 35.8),
1462, 1431, 1279, 1263, 1203, 1164, 1019, 904, 824, 757, 733,
1
128.6 (d, J PC ) 9.7), 128.8 (d, J PC ) 52.1), 131.0 (d, J PC ) 2.4),
693; H NMR (CDCl3) δ (ppm) 0.40-1.86 (3H, br), 2.24 (3H,
1
132.0 (d, J PC ) 8.5); 31P NMR (CDCl3) δ (ppm) +16.2 (q, J PB
s), 3.59 (3H, s), 6.86-7.97 (13H, m); 13C NMR (CDCl3) δ (ppm)
20.7 (s), 55.4 (s), 111.7 (s), 112.1 (d, J PC ) 4.8), 115-136, 150.6
(d, J PC ) 5), 161.5 (d, J PC ) 2.6); 31P NMR (CDCl3) δ (ppm)
) 40.1); MS (DCI, CH4) m/z (relative intensity) 236 (M+ + CH4;
25), 217 (M+ - 3H; 75), 206 (M+ - BH3; 8), 171 (25), 154 (100),
136 (16), 124 (18); HRMS (DCI, CH4) calcd for C13H19BP [M+
- 3H] 217.1317, found 217.1324. Anal. Calcd for C13H22BP
(220.1006): C, 70.94; H, 10.07. Found: C, 70.94; H, 10.24.
The enantiomeric excess of the cyclohexylmethylphenylphos-
1
108,72 (q, J PB ) 74.4); MS (EI) m/z (relative intensity) 335
(M+ - H; 100), 323 (66), 216 (29), 215 (99), 91 (85). Anal. Calcd
(29) Hideyuki, T.; Imamoto, T. Synlett 2001, 999-1002.
(30) Dunina, V. V.; Kuz′mina, L. G.; Kazakova, M. Y.; Grishin, Y.
K.; Veits, Y. A.; Kazakova, E. I. Tetrahedron: Asymmetry 1997, 8,
2537-2545.
(31) (a) Neetkoven, U.; Kamer, P. C. J .; van Leeuwen, Piet W. N.
M.; Widhalm, M.; Spek, A. L.; Lutz, M. J . Org. Chem. 1999, 64, 3996-
4004. (b) Ewalds, R.; Eggeling, E. B.; Hewat, A. C.; Kamer, P. C. J .;
van Leeuwen, Piet W. N. M.; Vogt, D. Chem. Eur. J . 2000, 6, 1496-
1504.
1
phine borane 12g was determined by H NMR and 31P NMR
analysis of the crude methylcyclohexyl phenylphosphine oxide,
in the presence of the (S)-(+)-N-(3,5-dinitrobenzoyl)-R-phenyl-
ethylamine as the chemical shift reagent.26 The phosphine
(27) Al-Masum, M.; Kumaraswamy, G.; Livinghouse, T. J . Org.
Chem. 2000, 65, 4776-4778.
(28) Stoop, R.; Mezzetti, A.; Spindler, F. Organometallics 1998, 17,
668-675.
(32) Rippert, A. J .; Linden, A.; Hansen, H. J . Helv. Chim. Acta 2000,
83, 311-321.
4300 J . Org. Chem., Vol. 68, No. 11, 2003